# Supernus Pharmaceuticals, Inc.: Form 8-K, filed Oct 29, 2026

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K
- Filed: 2026-10-29
- Accepted by EDGAR: Oct 29, 2026, 16:08 ET
- Period: 2026-10-29
- Accession: 0001356576-26-000050
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000050/supn-20261029.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000135657626000050/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000135657626000050/supn-20261029.htm

Filed Oct 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001356576-26-000050. Last ingested by Listed: Nov 4, 2026, 18:21 ET. No prices; not investment advice.